Abbott Laboratories (Pakistan) Limited (ABOT): Riding the Pharma Growth Wave
Abbott Laboratories (Pakistan) Limited (ABOT) has emerged as one of the standout players in the pharmaceutical sector this year. The company’s performance in the April–June...
Pharma Stock Valuations Are at a Discount, Is Now the Time to Buy?
Pakistan’s pharmaceutical sector has quietly morphed into a compelling value play. Despite major regulatory relief, margin expansion, and earnings growth, valuations across the board remain...
Can Pakistan’s local drugmakers outperform multinationals?
Pakistan’s pharmaceutical sector has entered a phase of structural transformation, and one question stands out: Can local drug manufacturers truly outperform multinational companies (MNCs)? Based...
Abbott’s comeback plan: why reintroduced drugs could boost future earnings?
Abbott Laboratories (Pakistan) Ltd, (ABOT) one of the country’s top multinational pharmaceutical players, is taking a bold step to reintroduce several previously discontinued products. This...
Pharma sector earnings rise, valuations fall: is it a buying opportunity?
The pharmaceutical sector in Pakistan delivered a strong performance in 1QCY25, with listed companies showing robust profitability driven by favorable macro and regulatory developments. Using...
ABOT EPS Forecast
According to our database, the following research houses have published their ABOT EPS Forecast